Back
Rhythm Pharmaceuticals Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
49.30
Seasonality Move:
5.37%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.35 | Buy |
| 20-day SMA: | 47.19 | Buy |
| 50-day SMA: | 47.04 | Buy |
| 200-day SMA: | 42.95 | Buy |
| 8-day EMA: | 48.61 | Buy |
| 20-day EMA: | 47.6 | Buy |
| 50-day EMA: | 46.29 | Buy |
| 200-day EMA: | 41.02 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 56.67 | Buy |
| Chaikin Money Flow: | 333879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.98 - 48.54) | Buy |
| Bollinger Bands (100): | (39.04 - 47.76) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 49.31 while RYTM 8-day simple moving average is 48.35, which is a Buy signal.
- The stock price of RYTM is 49.31 while Rhythm Pharmaceuticals 20-day SMA is 47.19, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 47.04 while RYTM share price is 49.31, making it a Buy technically.
- RYTM stock price is 49.31 and Rhythm Pharmaceuticals 200-day simple moving average is 42.95, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $49.31. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.01B
Price in USD:
49.31
Share Volume:
419.05K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
53.92
52-Week Low:
20.97
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 49.31 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 49.31 while RYTM 8-day exponential moving average is 48.61, which is a Buy signal.
- The stock price of RYTM is 49.31 while Rhythm Pharmaceuticals 20-day EMA is 47.60, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 46.29 while RYTM share price is 49.31, making it a Buy technically.
- RYTM stock price is 49.31 and Rhythm Pharmaceuticals 200-day simple moving average is 41.02, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 0.83, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 56.67, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (44.98 - 48.54), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (39.04 - 47.76), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.